Avid Technology (AVID) 10-Q 30 Oct 20 2020 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information	9 Months Ended
	Sep. 30, 2020shares
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2020
Document Transition Report	false
Entity File Number	1-36254
Entity Registrant Name	Avid Technology, Inc.
State of Incorporation	DE
Entity Tax Identification Number	04-2977748
Entity Address, Address Line One	75 Network Drive
Entity Address, City or Town	Burlington
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	01803
City Area Code	978
Local Phone Number	640-6789
Title of Security	Common Stock, $.01 par value
Trading Symbol	AVID
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	44,208,119
Entity Central Index Key	0000896841
Amendment Flag	false
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Net revenues:
Revenues	$ 90,431	$ 93,461	$ 256,165	$ 295,481
Cost of revenues:
Total cost of revenues	32,174	35,603	93,195	119,681
Gross profit	58,257	57,858	162,970	175,800
Operating expenses:
Research and development	13,623	14,860	42,116	46,325
Marketing and selling	19,998	22,334	64,977	73,341
General and administrative	10,796	12,034	34,144	38,543
Amortization of intangible assets	0	0	0	695
Restructuring costs, net	723	229	1,008	518
Total operating expenses	45,140	49,457	142,245	159,422
Operating income	13,117	8,401	20,725	16,378
Interest and other expense, net	(4,423)	(5,519)	(15,204)	(23,994)
Income (loss) before income taxes	8,694	2,882	5,521	(7,616)
Provision for income taxes	707	(283)	1,546	155
Net income (loss)	$ 7,987	$ 3,165	$ 3,975	$ (7,771)
Net income (loss) per common share – basic and diluted	$ 0.18	$ 0.07	$ 0.09	$ (0.18)
Weighted-average common shares outstanding – basic	44,019	42,913	43,665	42,510
Weighted-average common shares outstanding – diluted	44,758	43,674	44,498	42,510
Products
Net revenues:
Revenues	$ 35,775	$ 42,911	$ 98,121	$ 147,633
Cost of revenues:
Cost of revenues	20,957	23,877	58,873	79,535
Services
Net revenues:
Revenues	54,656	50,550	158,044	147,848
Cost of revenues:
Cost of revenues	11,217	11,726	34,322	36,408
Amortization of intangible assets
Cost of revenues:
Amortization of intangible assets	$ 0	$ 0	$ 0	$ 3,738

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Net income (loss)	$ 7,987	$ 3,165	$ 3,975	$ (7,771)
Other comprehensive income (loss):
Foreign currency translation adjustments	995	(764)	1,114	(602)
Comprehensive income (loss)	$ 8,982	$ 2,401	$ 5,089	$ (8,373)

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 49,142	$ 69,085
Restricted cash	1,664	1,663
Accounts receivable, net of allowances	59,683	73,773
Inventories	28,378	29,166
Prepaid expenses	10,526	9,425
Contract assets	15,276	19,494
Other current assets	2,608	6,125
Total current assets	167,277	208,731
Property and equipment, net	18,884	19,580
Goodwill	32,643	32,643
Right of use assets	30,408	29,747
Long-term deferred tax assets, net	6,539	7,479
Other long-term assets	5,651	6,113
Total assets	261,402	304,293
Current liabilities:
Accounts payable	13,450	39,888
Accrued compensation and benefits	30,452	19,524
Accrued expenses and other current liabilities	34,758	36,759
Income taxes payable	1,946	1,945
Short-term debt	4,135	30,554
Deferred revenues	70,858	83,589
Total current liabilities	155,599	212,259
Long-term debt	204,074	199,034
Long-term deferred revenues	10,306	14,312
Long-term lease liabilities	29,473	28,127
Other long-term liabilities	6,162	5,646
Total liabilities	405,614	459,378
Commitments and Contingencies (Note 8)
Stockholders' deficit:
Common stock	439	430
Additional paid-in capital	1,033,599	1,027,824
Accumulated deficit	(1,175,434)	(1,179,409)
Accumulated other comprehensive loss	(2,816)	(3,930)
Total stockholders' deficit	(144,212)	(155,085)
Total liabilities and stockholders' deficit	$ 261,402	$ 304,293

CONSOLIDATED BALANCE SHEETS (PA

CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Allowance for doubtful accounts	$ 1,522	$ 958

CONSOLDATED STATEMENTS OF STOCK

CONSOLDATED STATEMENTS OF STOCKHOLDERS' DEFICIT Statement - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	AOCI Attributable to Parent [Member]
Balances at beginning of period (in shares) at Dec. 31, 2018		42,339			(391)
Balances at beginning of period at Dec. 31, 2018	$ (166,661)	$ 423	$ 1,028,924	$ (1,187,010)	$ (5,231)	$ (3,767)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		0			391
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(1,381)	$ 0	(6,612)	0	$ 5,231	0
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	1,738		1,738
Net Income (Loss) Attributable to Parent	(213)			(213)
Other Comprehensive Income (Loss), Net of Tax	(548)					(548)
Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt	(23)		(23)
Capped Call Transaction Cost Reimbursement	1		1
Balances at end of period (in shares) at Mar. 31, 2019		42,339			0
Balances at end of period at Mar. 31, 2019	(167,087)	$ 423	1,024,028	(1,187,223)	$ 0	(4,315)
Balances at beginning of period (in shares) at Dec. 31, 2018		42,339			(391)
Balances at beginning of period at Dec. 31, 2018	(166,661)	$ 423	1,028,924	(1,187,010)	$ (5,231)	(3,767)
Net Income (Loss) Attributable to Parent	(7,771)
Balances at end of period (in shares) at Sep. 30, 2019		43,007			0
Balances at end of period at Sep. 30, 2019	(172,925)	$ 429	1,025,796	(1,194,781)	$ 0	(4,369)
Balances at beginning of period (in shares) at Mar. 31, 2019		42,339			0
Balances at beginning of period at Mar. 31, 2019	(167,087)	$ 423	1,024,028	(1,187,223)	$ 0	(4,315)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		381			0
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(200)	$ 4	(204)	0	$ 0	0
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	2,005		2,005
Net Income (Loss) Attributable to Parent	(10,723)			(10,723)
Other Comprehensive Income (Loss), Net of Tax	710					710
Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt	(554)		(554)
Capped Call Transaction Cost Reimbursement	26		26
Balances at end of period (in shares) at Jun. 30, 2019		42,720			0
Balances at end of period at Jun. 30, 2019	(175,823)	$ 427	1,025,301	(1,197,946)	$ 0	(3,605)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		287			0
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(1,548)	$ 2	(1,550)	0	$ 0	0
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	2,045		2,045
Net Income (Loss) Attributable to Parent	3,165			3,165
Other Comprehensive Income (Loss), Net of Tax	(764)					(764)
Balances at end of period (in shares) at Sep. 30, 2019		43,007			0
Balances at end of period at Sep. 30, 2019	(172,925)	$ 429	1,025,796	(1,194,781)	$ 0	(4,369)
Balances at beginning of period (in shares) at Dec. 31, 2019		43,150			0
Balances at beginning of period at Dec. 31, 2019	(155,085)	$ 430	1,027,824	(1,179,409)	$ 0	(3,930)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		398			0
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(1,814)	$ 4	(1,818)	0	$ 0	0
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	2,109		2,109
Net Income (Loss) Attributable to Parent	(5,857)			(5,857)
Other Comprehensive Income (Loss), Net of Tax	(815)					(815)
Balances at end of period (in shares) at Mar. 31, 2020		43,548			0
Balances at end of period at Mar. 31, 2020	(161,462)	$ 434	1,028,115	(1,185,266)	$ 0	(4,745)
Balances at beginning of period (in shares) at Dec. 31, 2019		43,150			0
Balances at beginning of period at Dec. 31, 2019	(155,085)	$ 430	1,027,824	(1,179,409)	$ 0	(3,930)
Net Income (Loss) Attributable to Parent	3,975
Balances at end of period (in shares) at Sep. 30, 2020		44,123			0
Balances at end of period at Sep. 30, 2020	(144,212)	$ 439	1,033,599	(1,175,434)	$ 0	(2,816)
Balances at beginning of period (in shares) at Mar. 31, 2020		43,548			0
Balances at beginning of period at Mar. 31, 2020	(161,462)	$ 434	1,028,115	(1,185,266)	$ 0	(4,745)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		368			0
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	(535)	$ 3	(538)	0	$ 0	0
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	2,726		2,726
Net Income (Loss) Attributable to Parent	1,845			1,845
Other Comprehensive Income (Loss), Net of Tax	934					934
Balances at end of period (in shares) at Jun. 30, 2020		43,916			0
Balances at end of period at Jun. 30, 2020	(156,492)	$ 437	1,030,303	(1,183,421)	$ 0	(3,811)
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture		207			0
Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture	1	$ 2	(1)	0	$ 0	0
APIC, Share-based Payment Arrangement, Increase for Cost Recognition	3,297		3,297
Net Income (Loss) Attributable to Parent	7,987			7,987
Other Comprehensive Income (Loss), Net of Tax	995					995
Balances at end of period (in shares) at Sep. 30, 2020		44,123			0
Balances at end of period at Sep. 30, 2020	$ (144,212)	$ 439	$ 1,033,599	$ (1,175,434)	$ 0	$ (2,816)

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net income (loss)	$ 3,975	$ (7,771)
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:
Depreciation and amortization	6,317	11,469
Recovery from doubtful accounts	1,349	(156)
Stock-based compensation expense	8,132	5,788
Non-cash interest expense	3,408	7,054
Loss (gain) on extinguishment of debt	0	2,878
Unrealized foreign currency transaction losses (gains)	219	237
Provision for (benefit from) deferred taxes	997	(886)
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	12,741	14,192
Inventories	788	788
Prepaid expenses and other assets	1,390	(3,526)
Accounts payable	(26,440)	(3,661)
Accrued expenses, compensation and benefits and other liabilities	7,752	(13,035)
Income taxes payable	81	372
Deferred revenue and contract assets	(12,519)	(12,631)
Net cash provided by (used in) operating activities	8,843	1,112
Cash flows from investing activities:
Purchases of property and equipment	(5,619)	(5,629)
Net cash used in investing activities	(5,619)	(5,629)
Cash flows from financing activities:
Proceeds from revolving line of credit	22,000	0
Repayments of Lines of Credit	(22,000)
Proceeds from long-term debt	7,800	79,286
Repayment of debt	(1,474)	(1,113)
Payments for repurchase of outstanding notes	(28,867)	(76,269)
Proceeds from the issuance of common stock under employee stock plans	252	309
Common stock repurchases for tax withholdings for net settlement of equity awards	(2,610)	(3,444)
Partial unwind capped call cash receipt	875	27
Payments for credit facility issuance costs	(289)	(5,979)
Net cash (used in) provided by financing activities	(24,313)	(7,183)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	1,394	(615)
Net increase (decrease) in cash, cash equivalents and restricted cash	(19,695)	(12,315)
Cash, cash equivalents and restricted cash at beginning of period	72,575	68,094
Cash, cash equivalents and restricted cash at end of period	52,880	55,779
Supplemental Cash Flow Information [Abstract]
Cash and cash equivalents at end of period	49,142	52,289
Restricted cash	1,664	1,664
Restricted cash included in other long-term assets	2,074	1,826
Cash paid (refunded) for income taxes	(659)	941
Cash paid for interest	$ 13,579	$ 7,780

FINANCIAL INFORMATION (Notes)

FINANCIAL INFORMATION (Notes)	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
FINANCIAL INFORMATION	FINANCIAL INFORMATION The accompanying condensed consolidated financial statements include the accounts of Avid Technology, Inc. and its wholly owned subsidiaries (collectively, “we” or “our”). These financial statements are unaudited. However, in the opinion of management, the condensed consolidated financial statements reflect all normal and recurring adjustments necessary for their fair statement. Interim results are not necessarily indicative of results expected for any other interim period or a full year. We prepared the accompanying unaudited condensed consolidated financial statements in accordance with the instructions for Form 10-Q and, therefore, include all information and footnotes necessary for a complete presentation of operations, comprehensive income (loss), financial position, changes in stockholders’ deficit, and cash flows in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The accompanying condensed consolidated balance sheet as of December 31, 2019 was derived from our audited consolidated financial statements and does not include all disclosures required by U.S. GAAP for annual financial statements. We filed audited consolidated financial statements as of and for the year ended December 31, 2019 in our Annual Report on Form 10-K for the year ended December 31, 2019, which included information and footnotes necessary for such presentation. The financial statements contained in this Form 10-Q should be read in conjunction with the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2019. The consolidated results of operations for the three months ended September 30, 2020 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2020. The Company’s results of operations are affected by economic conditions, including macroeconomic conditions and levels of business and consumer confidence. The COVID-19 pandemic has adversely affected the Company’s results of operations and financial condition, primarily due to reduced demand for our products and services which has led to lower net revenues. These economic impacts are the result of, but not limited to: • the postponement or cancellation of film and television productions, major sporting events, and live music events; • delays in purchasing and projects by our enterprise customers and channel partners; • disruption to the supply chain caused by distribution and other logistical issues, including disruptions arising from government restrictions; and • decreased productivity due to travel restrictions, work-from-home policies or shelter-in-place orders. These effects are expected to continue, although the full impact of the COVID-19 pandemic on the Company’s consolidated results of operations and financial condition over the longer term is uncertain. The Company is actively managing its business to respond to this health crisis and will continue to evaluate the nature and extent of the impact. We expect that our business operations and results of operations will be adversely impacted by these developments for at least the balance of 2020, and possibly longer. To address actual and expected reductions in net revenues, we have reduced our discretionary spending and reduced payroll costs, including through temporary employee furloughs and pay cuts. In addition, in May 2020 we received $7.8 million of funding under the U.S. government’s Paycheck Protection Program (the “PPP”) in the form of a low-interest loan that may be forgiven under certain conditions. We may be required to take additional remedial steps, depending on the duration and severity of the pandemic and its impact on our operations and cash flows, which could include, among other things (and where allowed by the lenders), (i) further cost reductions, (ii) seeking replacement financing, (iii) raising funds through the issuance of additional equity or debt securities or the incurrence of additional borrowings, (iv) disposing of certain assets or businesses, or (v) seeking additional funding under various programs implemented by the U.S. government in response to the COVID-19 pandemic. Such remedial actions, which may not be available on favorable terms or at all, could have a material adverse impact on our business, and/or could result in non-compliance with financial covenants in our financing agreements with lenders which, in the absence of a waiver or amendment, could result in an event of default under such financing agreements, which could permit acceleration of the outstanding indebtedness and require us to repay such indebtedness before the scheduled due date. If an event of default were to occur, we might not have sufficient funds available to make the payments required. If we are unable to repay amounts owed, the lenders may be entitled to foreclose on and sell substantially all of our assets, which secure our borrowings. We anticipate that we will have sufficient internal and external sources of liquidity to fund operations and anticipated working capital and other expected cash needs for at least the next 12 months as well as for the foreseeable future. We also believe that our financial resources will allow us to manage the anticipated impact of COVID-19 on our business operations and results of operations for the foreseeable future, which could include reductions in revenue and delays in payments from customers and partners. The challenges posed by COVID-19 on our business are expected to evolve rapidly. Consequently, we will continue to evaluate our financial position in light of future developments, particularly those relating to COVID-19. Our preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reported periods. Actual results could differ from our estimates. Significant Accounting Policies - Revenue Recognition We enter into contracts with customers that include various combinations of products and services, which are typically capable of being distinct and are accounted for as separate performance obligations. We account for a contract when (i) it has approval and commitment from both parties, (ii) the rights of the parties have been identified, (iii) payment terms have been identified, (iv) the contract has commercial substance, and (v) collectibility is probable. We recognize revenue upon transfer of control of promised products or services to customers, which typically occurs upon shipment or delivery depending on the terms of the underlying contracts, in an amount that reflects the consideration we expect to receive in exchange for those products or services. We often enter into contractual arrangements that have multiple performance obligations, one or more of which may be delivered subsequent to the delivery of other performance obligations. These arrangements may include a combination of products, support, training, and professional services. We allocate the transaction price of the arrangement based on the relative estimated standalone selling price of each distinct performance obligation. See Note 9 for disaggregated revenue schedules and further discussion on revenue and deferred revenue performance obligations and the timing of revenue recognition. Recent Accounting Pronouncements Recently Adopted Accounting Pronouncements On January 1, 2019, we adopted ASC 842 using the modified retrospective transition approach, as provided by ASU No. 2018-11, Leases - Targeted Improvements (“ASU 2018-11”). We elected the package of practical expedients permitted under the transition guidance. Results for reporting periods beginning after January 1, 2019 are presented under ASC 842, while prior periods have not been adjusted and continue to be reported in accordance with our historic accounting under previous U.S. GAAP. The primary impact of ASC 842 is that substantially all of our leases are recognized on the balance sheet, by recording right-of-use assets and short-term and long-term lease liabilities, both of which are material to our consolidated balance sheet. The new standard does not have a material impact on our consolidated statement of operations and cash flows, and the effect of applying ASC 842 as a cumulative-effect adjustment to retained earnings as of January 1, 2019 is immaterial. Recent Accounting Pronouncements To Be Adopted In December 2019, the Financial Accounting Standards Board (“FASB”) issued ASU 2019-12, Simplifying the Accounting for Income Taxes (“ASU 2019-12”). ASU 2019-12 is intended to enhance and simplify aspects of the income tax accounting guidance in ASC 740 as part of the FASB's simplification initiative. This guidance is effective for fiscal years and interim periods within those years beginning after December 15, 2020 with early adoption permitted. The Company is currently evaluating the impact this guidance may have on its consolidated financial statements and related disclosures. In March 2020, the FASB issued ASU 2020-04, Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”). ASU 2020-04 is intended to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens related to the

NET INCOME PER SHARE Earnings P

NET INCOME PER SHARE Earnings Per Share (Notes)	9 Months Ended
	Sep. 30, 2020
Earnings Per Share [Abstract]
NET INCOME PER SHARE	NET INCOME (LOSS) PER SHARE Net income (loss) per common share is presented for both basic income (loss) per share (“Basic EPS”) and diluted income (loss) per share (“Diluted EPS”). Basic EPS is based on the weighted-average number of common shares outstanding during the period. Diluted EPS is based on the weighted-average number of common shares and common share equivalents outstanding during the period. The potential common shares that were considered anti-dilutive securities were excluded from the diluted earnings per share calculations for the relevant periods either because the sum of the exercise price per share and the unrecognized compensation cost per share was greater than the average market price of our common stock for the relevant periods, or because they were considered contingently issuable. The contingently issuable potential common shares result from certain stock options and restricted stock units granted to our employees that vest based on performance conditions, market conditions, or a combination of performance and market conditions. The following table sets forth (in thousands) potential common shares that were considered anti-dilutive securities at September 30, 2020 and 2019. September 30, 2020 September 30, 2019 Options 390 594 Non-vested restricted stock units 3,220 2,699 Anti-dilutive potential common shares 3,610 3,293 The following table sets forth (in thousands) the basic and diluted weighted common shares outstanding for the three and nine months ended September 30, 2020. Three months ended Nine months ended Weighted common shares outstanding - basic 44,019 43,665 Net effect of common stock equivalents 739 833 Weighted common shares outstanding - diluted 44,758 44,498

FAIR VALUE MEASUREMENTS (Notes)

FAIR VALUE MEASUREMENTS (Notes)	9 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	FAIR VALUE MEASUREMENTS Assets Measured at Fair Value on a Recurring Basis We measure deferred compensation investments on a recurring basis. As of September 30, 2020 and December 31, 2019, our deferred compensation investments were classified as either Level 1 or Level 2 in the fair value hierarchy. Assets valued using quoted market prices in active markets and classified as Level 1 are money market and mutual funds. Assets valued based on other observable inputs and classified as Level 2 are insurance contracts. The following tables summarize our deferred compensation investments measured at fair value on a recurring basis (in thousands): Fair Value Measurements at Reporting Date Using September 30, Quoted Prices in Significant Significant Financial assets: Deferred compensation assets $ 487 $ 261 $ 226 $ — Fair Value Measurements at Reporting Date Using December 31, 2019 Quoted Prices in Significant Significant Financial assets: Deferred compensation assets $ 1,156 $ 338 $ 818 $ — Financial Instruments Not Recorded at Fair Value The carrying amounts of our other financial assets and liabilities including cash, accounts receivable, accounts payable, and accrued liabilities approximate their respective fair values because of the relatively short period of time between their origination and their expected realization or settlement.

INVENTORIES (Notes)

INVENTORIES (Notes)	9 Months Ended
	Sep. 30, 2020
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES Inventories consisted of the following (in thousands): September 30, 2020 December 31, 2019 Raw materials $ 7,885 $ 9,036 Work in process 316 371 Finished goods 20,177 19,759 Total $ 28,378 $ 29,166

LEASES LEASES (Notes)

LEASES LEASES (Notes)	9 Months Ended
	Sep. 30, 2020
Leases [Abstract]
LEASES	LEASES We have entered into a number of facility leases to support our research and development activities, sales operations, and other corporate and administrative functions in North America, Europe, and Asia, which qualify as operating leases under U.S. GAAP. We also have a limited number of equipment leases that qualify as either operating or finance leases. We determine if contracts with vendors represent a lease or have a lease component under U.S. GAAP at contract inception. Our leases have remaining terms ranging from less than one year to eight years. Some of our leases include options to extend or terminate the lease prior to the end of the agreed upon lease term. For purposes of calculating lease liabilities, lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise such options. Operating lease right of use assets and liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the lease commencement date. As our leases generally do not provide an implicit rate, we use an estimated incremental borrowing rate in determining the present value of future payments. The incremental borrowing rate represents an estimate of the interest rate we would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease within a particular location and currency environment. We used an average incremental borrowing rate of 6% as of January 1, 2019, the adoption date of ASC 842, for our leases that commenced prior to that date. The operating leases are included in “Right of use assets,” “Accrued expenses and other current liabilities,” and “Long-term lease liabilities” on our condensed consolidated balance sheets as of September 30, 2020 and December 31, 2019. Finance lease right of use assets and liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the lease commencement date. Each lease agreement provides an implicit discount rate used to determine the present value of future payments. The weighted-average discount rate is 2.3% as of September 30, 2020, the commencement date for our leases. The finance leases are included in “Other assets” and “Other long-term liabilities” on our condensed consolidated balance sheet as of September 30, 2020. The weighted-average remaining lease term of our operating leases is 6.6 years as of September 30, 2020. Lease costs for minimum lease payments is recognized on a straight-line basis over the lease term. Our total operating lease costs were $2.2 million and $2.4 million for the three months ended September 30, 2020 and September 30, 2019, respectively. Our total operating lease costs were $7.2 million and $7.2 million for the nine months ended September 30, 2020 and September 30, 2019 respectively. Related cash payments were $2.0 million and $2.4 million for the three months ended September 30, 2020 and September 30, 2019, respectively. Related cash payments were $6.9 million and $7.3 million for the nine months ended September 30, 2020 and September 30, 2019, respectively. For the nine months ended September 30, 2020, right of use assets obtained in exchange for new operating lease liabilities was $5.7 million. Operating lease costs are included within research and development, marketing and selling, and general and administrative lines on the condensed consolidated statements of operations, and the related cash payments are included in the operating cash flows on the condensed consolidated statements of cash flows. Finance lease costs, short-term lease costs, variable lease costs, and sublease income are not material. The table below reconciles the undiscounted future minimum lease payments for operating and finance leases under non-cancelable leases with terms of more than one year to the total lease liabilities recognized on the condensed consolidated balance sheets as of September 30, 2020 (in thousands): Year Ending December 31, Operating Leases Finance Leases 2020 (excluding nine months ended September 30, 2020) $ 2,067 $ 12 2021 7,590 289 2022 6,472 255 2023 5,579 226 2024 4,875 — Thereafter 16,637 — Total future minimum lease payments $ 43,220 $ 782 Less effects of discounting (7,837) (27) Total lease liabilities $ 35,383 $ 755 Supplemental balance sheet information related to leases was as follows (in thousands): Operating Leases September 30, 2020 Right of use assets $ 30,408 Accrued expenses and other current liabilities (5,910) Operating lease liabilities (LT) (29,473) Total lease liabilities $ (35,383) Finance Leases September 30, 2020 Other assets $ 737 Accrued expenses and other current liabilities (220) Other long-term liabilities (535) Total lease liabilities $ (755)

OTHER LONG-TERM LIABILITIES (No

OTHER LONG-TERM LIABILITIES (Notes)	9 Months Ended
	Sep. 30, 2020
Other Liabilities Disclosure [Abstract]
OTHER LONG-TERM LIABILITIES	OTHER LONG-TERM LIABILITIES Other long-term liabilities consisted of the following (in thousands): September 30, 2020 December 31, 2019 Deferred compensation $ 5,335 $ 5,186 Finance leases 535 — Other 292 460 Total $ 6,162 $ 5,646

CONTINGENCIES (Notes)

CONTINGENCIES (Notes)	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Commitments We entered into a long-term agreement to purchase a variety of information technology solutions from a third party in the second quarter of 2020, which included an unconditional commitment to purchase a minimum of $32.2 million of products and services over the initial five years of the agreement. We have purchased $0.6 million of products and services pursuant to this agreement as of September 30, 2020. We have letters of credit that are used as security deposits in connection with our leased Burlington, Massachusetts office space. In the event of default on the underlying leases, the landlords would, at September 30, 2020, be eligible to draw against the letters of credit to a maximum of $1.3 million in the aggregate. The letters of credit are subject to aggregate reductions provided that we are not in default under the underlying leases and meet certain financial performance conditions. In no case will the letters of credit amounts for the Burlington leases be reduced to below $1.2 million in the aggregate throughout the lease periods. We also have letters of credit in connection with security deposits for other facility leases totaling $0.6 million in the aggregate, as well as letters of credit totaling $1.9 million that otherwise support our ongoing operations. These letters of credit have various terms and expire during 2020 and beyond, while some of the letters of credit may automatically renew based on the terms of the underlying agreements. Substantially all of our letters of credit are collateralized by restricted cash included in the caption “Restricted cash” and “Other long-term assets” on our condensed consolidated balance sheets as of September 30, 2020. Contingencies Our industry is characterized by the existence of a large number of patents and frequent claims and litigation regarding patent and other intellectual property rights. In addition to the legal proceedings described above, we are involved in legal proceedings from time to time arising from the normal course of business activities, including claims of alleged infringement of intellectual property rights and contractual, commercial, employee relations, product or service performance, or other matters. We do not believe these matters will have a material adverse effect on our financial position or results of operations. However, the outcome of legal proceedings and claims brought against us is subject to significant uncertainty. Therefore, our financial position or results of operations may be negatively affected by the unfavorable resolution of one or more of these proceedings for the period in which a matter is resolved. Our results could be materially adversely affected if we are accused of, or found to be, infringing third parties’ intellectual property rights. Following the termination of our former Chairman and Chief Executive Officer on February 25, 2018, we received a notice alleging that we breached the former executive’s employment agreement. On April 16, 2019 we received an additional notice again alleging we breached the former executive’s employment agreement. We have since been in communications with our former Chairman and Chief Executive Officer’s counsel. While we intend to defend any claim vigorously, when and if a claim is actually filed, we are currently unable to estimate an amount or range of any reasonably possible losses that could occur as a result of this matter. On July 14, 2020, we sent a notice to a customer demanding sums that we believe are due to Avid pursuant to a contract. On October 7, 2020, the customer sent a notice to us denying any legal liability and demanding payment for breach of contract resulting from various alleged delays by us. While we intend to defend any claim vigorously when and if a claim is actually filed, we are currently unable to estimate an amount or range of any reasonably possible losses that could occur related to this matter. We consider all claims on a quarterly basis and based on known facts assess whether potential losses are considered reasonably possible, probable, and estimable. Based upon this assessment, we then evaluate disclosure requirements and whether to accrue for such claims in our condensed consolidated financial statements. We record a provision for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are reviewed at least quarterly and adjusted to reflect the impacts of negotiations, settlements, rulings, advice of legal counsel, and other information and events pertaining to a particular case. At September 30, 2020 and as of the date of filing of these condensed consolidated financial statements, we believe that, other than as set forth in this note, no provision for liability nor disclosure is required related to any claims because: (a) there is no reasonable possibility that a loss exceeding amounts already recognized (if any) may be incurred with respect to such claim, (b) a reasonably possible loss or range of loss cannot be estimated, or (c) such estimate is immaterial. Additionally, we provide indemnification to certain customers for losses incurred in connection with intellectual property infringement claims brought by third parties with respect to our products. These indemnification provisions generally offer perpetual coverage for infringement claims based upon the products covered by the agreement and the maximum potential amount of future payments we could be required to make under these indemnification provisions is theoretically unlimited. To date, we have not incurred material costs related to these indemnification provisions; accordingly, we believe the estimated fair value of these indemnification provisions is immaterial. Further, certain of our arrangements with customers include clauses whereby we may be subject to penalties for failure to meet certain performance obligations; however, we have not recorded any related material penalties to date. We provide warranties on externally sourced and internally developed hardware. For internally developed hardware, and in cases where the warranty granted to customers for externally sourced hardware is greater than that provided by the manufacturer, we record an accrual for the related liability based on historical trends and actual material and labor costs. The following table sets forth the activity in the product warranty accrual account for the nine months ended September 30, 2020 and 2019 (in thousands): Nine Months Ended September 30, 2020 2019 Accrual balance at beginning of year $ 1,337 $ 1,706 Accruals for product warranties 1,030 732 Costs of warranty claims (1,003) (1,016) Accrual balance at end of period $ 1,364 $ 1,422 The warranty accrual is included in the caption “accrued expenses and other current liabilities” in our condensed consolidated balance sheet.

RESTRUCTURING COSTS AND ACCRUAL

RESTRUCTURING COSTS AND ACCRUALS (Notes)	9 Months Ended
	Sep. 30, 2020
Restructuring and Related Activities [Abstract]
RESTRUCTURING COSTS AND ACCRUALS	RESTRUCTURING COSTS AND ACCRUALS During the three months ended September 30, 2020 and September 30, 2019 , we recorded restructuring charges of $0.7 million and $0.2 million, respectively, for employee severance cost adjustments. During the nine months ended September 30, 2020 and September 30, 2019 we recorded restructuring charges of $1.0 million and $0.5 million respectively. Restructuring Summary The following table sets forth restructuring expenses recognized for the three and nine months ended September 30, 2020 and 2019 (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Employee $ 723 $ 202 $ 911 $ 473 Facility — — 97 5 Total facility and employee charges 723 202 1,008 478 Other — 27 — 40 Total restructuring charges, net $ 723 $ 229 $ 1,008 $ 518 The following table sets forth the activity in the restructuring accruals for the nine months ended September 30, 2020 (in thousands): Employee Accrual balance as of December 31, 2019 $ 155 Restructuring charges and revisions 911 Cash payments (258) Accrual balance as of September 30, 2020 808 Less: current portion 808 Long-term accrual balance as of September 30, 2020 $ — The employee restructuring accrual at September 30, 2020 represents severance costs to former employees that will be paid out within 12 months, and is, therefore, included in the caption “accrued expenses and other current liabilities” in our condensed consolidated balance sheets as of September 30, 2020. On January 1, 2019, we had facilities restructuring accruals of $0.1 million included in the caption “accrued expenses and other current liabilities” and $0.2 million included in the caption “other long-term liabilities," which were reclassified upon the adoption of ASC 842 to the right of use asset account.

LONG-TERM DEBT AND CREDIT AGREE

LONG-TERM DEBT AND CREDIT AGREEMENT (Notes)	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
LONG TERM DEBT AND CREDIT AGREEMENT	LONG-TERM DEBT AND CREDIT AGREEMENT Long-term debt consisted of the following (in thousands): September 30, 2020 December 31, 2019 Term Loan, net of debt issuance costs of $2,846 at September 30, 2020 and $3,334 at December 31, 2019 $ 199,159 $ 200,105 Notes, net of unamortized original issue discount and debt issuance costs of $0 at September 30, 2020 and $680 at December 31, 2019 — 28,187 PPP Loan 7,800 — Other long-term debt 1,250 1,296 Total debt 208,209 229,588 Less: current portion 4,135 30,554 Total long-term debt $ 204,074 $ 199,034 The following table summarizes the contractual maturities of our borrowing obligations as of September 30, 2020 (in thousands): Fiscal Year Term Loan PPP Loan Other Long-Term Debt Total 2020 $ 797 $ — $ 36 $ 833 2021 4,781 — 153 4,934 2022 6,375 7,800 164 14,339 2023 190,052 — 176 190,228 2024 — — 188 188 Thereafter — — 533 533 Total before unamortized discount 202,005 7,800 1,250 211,055 Less: unamortized discount and issuance costs 2,846 — — 2,846 Less: current portion of long-term debt 3,985 — 150 4,135 Total long-term debt $ 195,174 $ 7,800 $ 1,100 $ 204,074 Term Loan and Credit Facility On February 26, 2016, we entered into a financing agreement (the “Financing Agreement”) with Cerberus Business Finance, LLC, as collateral and administrative agent, and the lenders party thereto (the “Lenders”). The Lenders originally agreed to provide us with (a) a term loan in the aggregate principal amount of $100.0 million (the “Term Loan”), and (b) a revolving credit facility (the “Credit Facility”) of up to a maximum of $5.0 million in borrowings outstanding at any time. We granted a security interest on substantially all of our assets to secure the obligations under the Term Loan and the Credit Facility. The Term Loan requires us to use 50% of excess cash flow, as defined in the Financing Agreement, to repay outstanding principal of the loans under the Financing Agreement. The Financing Agreement contains customary representations and warranties, covenants, mandatory prepayments, and events of default under which our payment obligations may be accelerated. On November 9, 2017, we entered into an amendment and borrowed an additional $15.0 million term loan and increased the amount available under the Credit Facility by $5.0 million. On May 10, 2018, we entered into an amendment to the Financing Agreement, which extended the maturity of the Financing Agreement to May 2023, and increased the Term Loan by $22.7 million and the amount available under the Credit Facility by $12.5 million, for an aggregate amount available of $22.5 million. On April 8, 2019, we entered into an amendment to the Financing Agreement. The amendment provided for an additional delayed draw term loan commitment in the aggregate principal amount of $100.0 million (the “Delayed Draw Funds”) for the purpose of funding the purchase of a portion of Notes in the Offer described below. On May 2, 2019, we received the Delayed Draw Funds under the Financing Agreement. We used $72.7 million of the Delayed Draw Funds for the purchase of a portion of our Notes, $0.6 million for the Notes interest payment, and $6.0 million for the payment of refinancing fees. On June 18, 2019, we repaid $20.7 million of the Delayed Draw Funds. The $79.3 million Delayed Draw Funds borrowed and that remain outstanding will mature on May 10, 2023 under the terms of the Financing Agreement. The amendment also modified the covenant that requires us to maintain a leverage ratio (defined to mean the ratio of (a) the sum of indebtedness under the Term Loan and Credit Facility and non-cash collateralized letters of credit to (b) consolidated EBITDA under the Term Loan and Credit Facility) based on the level of availability of our Credit Facility plus unrestricted cash on-hand. The Financing Agreement amendment effective April 8, 2019 was accounted for as a debt modification, and therefore, $1.6 million of the refinancing fees paid directly to the Lenders was recorded as deferred debt issuance costs, and $4.4 million of the refinancing fees paid to the third parties was expensed. On May 7, 2020, we entered into an amendment to the Financing Agreement. The amendment modified certain definitions in the Financing Agreement to reflect our incurrence of a loan under the PPP. On May 19, 2020, we entered into an amendment to the Financing Agreement. The amendment increased the applicable margin with respect to the interest rate of reference rate loans from 5.25% to 5.75% and of LIBOR rate loans from 6.25% to 6.75%. The amendment also increased the leverage ratio that the Company is required to maintain such that following the effective date of this amendment, the Company is required to maintain a leverage ratio of no greater than 6.00:1.00 for each of the quarters ending June 30, 2020 and September 30, 2020, 5.75:1.00 for each of the quarters ending December 31, 2020 and March 31, 2021, 5.25:1.00 for the quarter ending June 30, 2021, 5.00:1.00 for the quarter ending September 30, 2021, 4.50:1.00 for the quarter ending December 31, 2021, 4.30:1.00 for the quarter ending March 31, 2022, 4.00:1.00 for each of the quarters ending June 30, 2022 and September 30, 2022, and 3.75:1.00 for each of the quarters ending December 31, 2022 and March 31, 2023. The amendment also resets the prepayment premium to 1.5% of the principal amount of the loans prepaid through the end of 2020, 0.5% of the principal amount of the loans prepaid through the end of 2021, and 0.0% thereafter. We recorded $3.8 million and $12.2 million of interest expense on the Term Loan during the three and nine months ended September 30, 2020, respectively. We recognized $0.4 million and $0.8 million of interest expense related to the Credit Facility during the three and nine months ended September 30, 2020, respectively. We were in compliance with the Financing Agreement covenants as of September 30, 2020. At June 30, 2020, we had $22.0 million outstanding under the Credit Facility. During September 2020, we repaid the outstanding balance of $22.0 million under the Credit Facility, and as of September 30, 2020 no amounts were drawn under the facility. PPP Loan On May 11, 2020, the Company received $7.8 million of proceeds in connection with its incurrence of a loan under the PPP which was created through the Coronavirus Aid, Relief, and Economic Act (“CARES Act”) and is administered by the U.S. Small Business Administration (“SBA”). The application for these funds requires the Company to, in good faith, certify that the current economic uncertainty made the loan request necessary to support the ongoing operations of the Company. This certification further requires the Company to take into account our current business activity and our ability to access other sources of liquidity sufficient to support ongoing operations in a manner that is not significantly detrimental to the business. The receipt of these funds, and the forgiveness of the loan attendant to these funds, is dependent on the Company having initially qualified for the loan and qualifying for the forgiveness of such loan based on our future adherence to the forgiveness criteria. The loan has a fixed interest rate of 1% and matures in two years. Interest payments are deferred for six months. We recognized an immaterial amount of interest expense related to the loan during the three months ended September 30, 2020. Pursuant to the CARES Act and implementing rules and regulations, the Company may apply to the SBA for the PPP loan to be forgiven in whole or in part beginning no sooner than seven weeks from the date of initial disbursement. The Company intends to use the proceeds of the PPP loan for purposes consistent with the PPP. While the Company currently believes that its use of the loan proceeds will meet the conditions for forgiveness of the loan, the Company cannot assure that it will be eligible for forgiveness of the loan, in whole or in part. Any PPP loan balance remaining following forgiveness by the SBA will be fully re-amortized over the remaining term of the loan. 2.00% Convertible Senior Notes due 2020 (“Notes”) On June 15, 2015, we issued $125.0 million aggregate principal amount of our Notes in an offering conducted in accordance with Rule 144A under the Securities Act. During 2017, we purchased 2,000 of our 125,000 outstanding Notes and settled $2.0 million of the Notes for $1.7 million in cash. We recorded $2.0 million extinguishment of debt, an immaterial amount of equity reacquisition, and an immaterial loss on the extinguishment of debt. During 2018, we purchased an additional 16,247 of our 123,000 outstanding Notes and settled another $16.2 million of the Notes for $14.7 million in cash. We recorded $16.2 million extinguishment of debt, an immaterial amount of equity reacquisition, and an immaterial gain on the extinguishment of debt. On January 22, 2019, we purchased an additional 3,900 of our 106,753 outstanding Notes and settled another $3.9 million of the Notes for $3.6 million in cash. We recorded $3.9 million extinguishment of debt, an immaterial amount of equity reacquisition, and an immaterial gain on the extinguishment of debt. On April 11, 2019, we announced the commencement of a cash tender offer (the “Offer”) for any and all of our outstanding Notes. On May 9, 2019, as of the expiration of the Offer, Notes with an aggregate principal amount of $74.0 million were validly tendered. We accepted for purchase all Notes that were validly tendered at the expiration of the Offer at a purchase price equal to $982.50 per $1,000 principal amount of Notes, and settled the Offer on May 13, 2019 for $72.7 million in cash. We repurchased 73,986 Notes, recorded $74.0 million extinguishment of debt, $0.6 million of equity reacquisition, and $2.9 million loss on the extinguishment of debt. In connection with the Offer, the number of options under the Capped Call was reduced to 28,867 to mirror the remaining principal outstanding for the Notes, and an immaterial partial unwind cash payment was received in May 2019. On June, 15, 2020, the maturity date of the Notes, we fully repaid the outstanding principal and unpaid interest on the Notes. The Notes paid interest semi-annually on June 15 and December 15 of each year at an annual rate of 2.00%. Total interest expense for the nine months ended September 30, 2020 was $1.0 million, reflecting the coupon and accretion of the discount.

STOCKHOLDERS' EQUITY (Notes)

STOCKHOLDERS' EQUITY (Notes)	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement [Abstract]
STOCKHOLDERS' EQUITY	STOCKHOLDERS’ EQUITY Stock-Based Compensation Information with respect to option shares granted under all of our stock incentive plans for the nine months ended September 30, 2020 was as follows: Time-Based Shares Performance-Based Shares Total Shares Weighted- Weighted- Aggregate Options outstanding at January 1, 2020 565,000 — 565,000 $7.57 Granted — — — $— Exercised (175,355) — (175,355) $7.73 Forfeited or canceled — — — $— Options outstanding at September 30, 2020 389,645 — 389,645 $7.51 0.54 $413 Options vested at September 30, 2020 or expected to vest 389,645 $7.51 0.54 $413 Options exercisable at September 30, 2020 389,645 $7.51 0.54 $413 Information with respect to our non-vested restricted stock units for the nine months ended September 30, 2020 was as follows: Non-Vested Restricted Stock Units Time-Based Shares Performance-Based Shares Total Shares Weighted- Weighted- Aggregate Non-vested at January 1, 2020 2,087,933 554,265 2,642,198 $6.40 Granted 1,424,480 578,316 2,002,796 $6.92 Vested (991,552) (328,673) (1,320,225) $6.23 Forfeited (104,473) — (104,473) $7.16 Non-vested at September 30, 2020 2,416,388 803,908 3,220,296 $6.77 1.03 $27,534 Expected to vest 3,220,296 $6.77 1.03 $27,534 Stock-based compensation was included in the following captions in our condensed consolidated statements of operations for the nine months ended September 30, 2020 and 2019 (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Cost of products revenues $ 150 $ 103 $ 370 $ 244 Cost of services revenues 283 82 539 177 Research and development expenses 546 305 1,199 762 Marketing and selling expenses 739 532 1,761 1,276 General and administrative expenses 1,579 1,023 4,263 3,329 $ 3,297 $ 2,045 $ 8,132 $ 5,788

FINANCIAL INFORMATION (Policies

FINANCIAL INFORMATION (Policies)	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Revenue from Contract with Customer	Significant Accounting Policies - Revenue Recognition We enter into contracts with customers that include various combinations of products and services, which are typically capable of being distinct and are accounted for as separate performance obligations. We account for a contract when (i) it has approval and commitment from both parties, (ii) the rights of the parties have been identified, (iii) payment terms have been identified, (iv) the contract has commercial substance, and (v) collectibility is probable. We recognize revenue upon transfer of control of promised products or services to customers, which typically occurs upon shipment or delivery depending on the terms of the underlying contracts, in an amount that reflects the consideration we expect to receive in exchange for those products or services. We often enter into contractual arrangements that have multiple performance obligations, one or more of which may be delivered subsequent to the delivery of other performance obligations. These arrangements may include a combination of products, support, training, and professional services. We allocate the transaction price of the arrangement based on the relative estimated standalone selling price of each distinct performance obligation. See Note 9 for disaggregated revenue schedules and further discussion on revenue and deferred revenue performance obligations and the timing of revenue recognition.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Recently Adopted Accounting Pronouncements On January 1, 2019, we adopted ASC 842 using the modified retrospective transition approach, as provided by ASU No. 2018-11, Leases - Targeted Improvements (“ASU 2018-11”). We elected the package of practical expedients permitted under the transition guidance. Results for reporting periods beginning after January 1, 2019 are presented under ASC 842, while prior periods have not been adjusted and continue to be reported in accordance with our historic accounting under previous U.S. GAAP. The primary impact of ASC 842 is that substantially all of our leases are recognized on the balance sheet, by recording right-of-use assets and short-term and long-term lease liabilities, both of which are material to our consolidated balance sheet. The new standard does not have a material impact on our consolidated statement of operations and cash flows, and the effect of applying ASC 842 as a cumulative-effect adjustment to retained earnings as of January 1, 2019 is immaterial. Recent Accounting Pronouncements To Be Adopted In December 2019, the Financial Accounting Standards Board (“FASB”) issued ASU 2019-12, Simplifying the Accounting for Income Taxes (“ASU 2019-12”). ASU 2019-12 is intended to enhance and simplify aspects of the income tax accounting guidance in ASC 740 as part of the FASB's simplification initiative. This guidance is effective for fiscal years and interim periods within those years beginning after December 15, 2020 with early adoption permitted. The Company is currently evaluating the impact this guidance may have on its consolidated financial statements and related disclosures. In March 2020, the FASB issued ASU 2020-04, Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”). ASU 2020-04 is intended to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens related to the

NET INCOME PER SHARE Earnings_2

NET INCOME PER SHARE Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2020
Earnings Per Share [Abstract]
Schedule of Antidilutive Securities Excluded From Computation of Net (Income) Loss Per Share	The following table sets forth (in thousands) potential common shares that were considered anti-dilutive securities at September 30, 2020 and 2019. September 30, 2020 September 30, 2019 Options 390 594 Non-vested restricted stock units 3,220 2,699 Anti-dilutive potential common shares 3,610 3,293
Schedule of Weighted Average Number of Shares	The following table sets forth (in thousands) the basic and diluted weighted common shares outstanding for the three and nine months ended September 30, 2020. Three months ended Nine months ended Weighted common shares outstanding - basic 44,019 43,665 Net effect of common stock equivalents 739 833 Weighted common shares outstanding - diluted 44,758 44,498

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
Financial assets and liabilities measured at fair value on a recurring basis	The following tables summarize our deferred compensation investments measured at fair value on a recurring basis (in thousands): Fair Value Measurements at Reporting Date Using September 30, Quoted Prices in Significant Significant Financial assets: Deferred compensation assets $ 487 $ 261 $ 226 $ — Fair Value Measurements at Reporting Date Using December 31, 2019 Quoted Prices in Significant Significant Financial assets: Deferred compensation assets $ 1,156 $ 338 $ 818 $ —

INVENTORIES (Tables)

INVENTORIES (Tables)	9 Months Ended
	Sep. 30, 2020
Inventory Disclosure [Abstract]
Inventories	Inventories consisted of the following (in thousands): September 30, 2020 December 31, 2019 Raw materials $ 7,885 $ 9,036 Work in process 316 371 Finished goods 20,177 19,759 Total $ 28,378 $ 29,166

LEASES LEASES (Tables)

LEASES LEASES (Tables)	9 Months Ended
	Sep. 30, 2020
Leases [Abstract]
Finance Lease, Liability, Maturity	The table below reconciles the undiscounted future minimum lease payments for operating and finance leases under non-cancelable leases with terms of more than one year to the total lease liabilities recognized on the condensed consolidated balance sheets as of September 30, 2020 (in thousands): Year Ending December 31, Operating Leases Finance Leases 2020 (excluding nine months ended September 30, 2020) $ 2,067 $ 12 2021 7,590 289 2022 6,472 255 2023 5,579 226 2024 4,875 — Thereafter 16,637 — Total future minimum lease payments $ 43,220 $ 782 Less effects of discounting (7,837) (27) Total lease liabilities $ 35,383 $ 755
Assets and Liabilities, Lessee	Supplemental balance sheet information related to leases was as follows (in thousands): Operating Leases September 30, 2020 Right of use assets $ 30,408 Accrued expenses and other current liabilities (5,910) Operating lease liabilities (LT) (29,473) Total lease liabilities $ (35,383) Finance Leases September 30, 2020 Other assets $ 737 Accrued expenses and other current liabilities (220) Other long-term liabilities (535) Total lease liabilities $ (755)

OTHER LONG-TERM LIABILITIES (Ta

OTHER LONG-TERM LIABILITIES (Tables)	9 Months Ended
	Sep. 30, 2020
Other Liabilities Disclosure [Abstract]
Long-term liabilities	Other long-term liabilities consisted of the following (in thousands): September 30, 2020 December 31, 2019 Deferred compensation $ 5,335 $ 5,186 Finance leases 535 — Other 292 460 Total $ 6,162 $ 5,646

CONTINGENCIES (Tables)

CONTINGENCIES (Tables)	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Product warranty accrual activity	The following table sets forth the activity in the product warranty accrual account for the nine months ended September 30, 2020 and 2019 (in thousands): Nine Months Ended September 30, 2020 2019 Accrual balance at beginning of year $ 1,337 $ 1,706 Accruals for product warranties 1,030 732 Costs of warranty claims (1,003) (1,016) Accrual balance at end of period $ 1,364 $ 1,422

RESTRUCTURING COSTS AND ACCRU_2

RESTRUCTURING COSTS AND ACCRUALS (Tables)	9 Months Ended
	Sep. 30, 2020
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Related Costs	The following table sets forth restructuring expenses recognized for the three and nine months ended September 30, 2020 and 2019 (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Employee $ 723 $ 202 $ 911 $ 473 Facility — — 97 5 Total facility and employee charges 723 202 1,008 478 Other — 27 — 40 Total restructuring charges, net $ 723 $ 229 $ 1,008 $ 518 The following table sets forth the activity in the restructuring accruals for the nine months ended September 30, 2020 (in thousands): Employee Accrual balance as of December 31, 2019 $ 155 Restructuring charges and revisions 911 Cash payments (258) Accrual balance as of September 30, 2020 808 Less: current portion 808 Long-term accrual balance as of September 30, 2020 $ —

REVENUE (Tables)

REVENUE (Tables)	9 Months Ended
	Sep. 30, 2020
Revenue from Contract with Customer [Abstract]
Revenue by Type	The following table is a summary of our revenues by type for the three and nine months ended September 30, 2020 and 2019 (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Products and solutions net revenues $ 35,775 $ 42,911 $ 98,121 $ 147,633 Subscription services 17,907 10,297 48,292 29,339 Support services 30,826 33,361 93,190 97,018 Professional services, training and other services 5,923 6,892 16,562 21,491 Total net revenues $ 90,431 $ 93,461 $ 256,165 $ 295,481
Revenue by Geographic Region	The following table sets forth our revenues by geographic region for the three and nine months ended September 30, 2020 and 2019 (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Revenues: United States $ 36,190 $ 31,267 $ 105,166 $ 110,697 Other Americas 4,505 9,471 15,841 23,232 Europe, Middle East and Africa 37,537 40,579 99,478 115,171 Asia-Pacific 12,199 12,144 35,680 46,381 Total net revenues $ 90,431 $ 93,461 $ 256,165 $ 295,481
Contract Asset	Contract Asset Contract asset activity for the nine months ended September 30, 2020 was as follows (in thousands): September 30, 2020 Contract asset at January 1, 2020 $ 19,494 Revenue in excess of billings 22,045 Customer billings (26,263) Contract asset at September 30, 2020 $ 15,276
Deferred Revenue	Deferred revenue activity for the nine months ended September 30, 2020 was as follows (in thousands): September 30, 2020 Deferred revenue at January 1, 2020 $ 97,901 Billings deferred 47,723 Recognition of prior deferred revenue (64,460) Deferred revenue at September 30, 2020 $ 81,164 A summary of the significant performance obligations included in deferred revenue as of September 30, 2020 is as follows (in thousands): September 30, 2020 Product $ 5,133 Subscription 3,320 Support contracts 61,596 Implied PCS 8,860 Professional services, training and other 2,255 Deferred revenue at September 30, 2020 $ 81,164

LONG-TERM DEBT AND CREDIT AGR_2

LONG-TERM DEBT AND CREDIT AGREEMENT (Tables)	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Schedule of Long-term Debt	Long-term debt consisted of the following (in thousands): September 30, 2020 December 31, 2019 Term Loan, net of debt issuance costs of $2,846 at September 30, 2020 and $3,334 at December 31, 2019 $ 199,159 $ 200,105 Notes, net of unamortized original issue discount and debt issuance costs of $0 at September 30, 2020 and $680 at December 31, 2019 — 28,187 PPP Loan 7,800 — Other long-term debt 1,250 1,296 Total debt 208,209 229,588 Less: current portion 4,135 30,554 Total long-term debt $ 204,074 $ 199,034
Schedule of Maturities of Long-term Debt	The following table summarizes the contractual maturities of our borrowing obligations as of September 30, 2020 (in thousands): Fiscal Year Term Loan PPP Loan Other Long-Term Debt Total 2020 $ 797 $ — $ 36 $ 833 2021 4,781 — 153 4,934 2022 6,375 7,800 164 14,339 2023 190,052 — 176 190,228 2024 — — 188 188 Thereafter — — 533 533 Total before unamortized discount 202,005 7,800 1,250 211,055 Less: unamortized discount and issuance costs 2,846 — — 2,846 Less: current portion of long-term debt 3,985 — 150 4,135 Total long-term debt $ 195,174 $ 7,800 $ 1,100 $ 204,074

STOCKHOLDERS' EQUITY (Tables)

STOCKHOLDERS' EQUITY (Tables)	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement [Abstract]
Share-based Payment Arrangement, Option, Activity	Information with respect to option shares granted under all of our stock incentive plans for the nine months ended September 30, 2020 was as follows: Time-Based Shares Performance-Based Shares Total Shares Weighted- Weighted- Aggregate Options outstanding at January 1, 2020 565,000 — 565,000 $7.57 Granted — — — $— Exercised (175,355) — (175,355) $7.73 Forfeited or canceled — — — $— Options outstanding at September 30, 2020 389,645 — 389,645 $7.51 0.54 $413 Options vested at September 30, 2020 or expected to vest 389,645 $7.51 0.54 $413 Options exercisable at September 30, 2020 389,645 $7.51 0.54 $413
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity	Information with respect to our non-vested restricted stock units for the nine months ended September 30, 2020 was as follows: Non-Vested Restricted Stock Units Time-Based Shares Performance-Based Shares Total Shares Weighted- Weighted- Aggregate Non-vested at January 1, 2020 2,087,933 554,265 2,642,198 $6.40 Granted 1,424,480 578,316 2,002,796 $6.92 Vested (991,552) (328,673) (1,320,225) $6.23 Forfeited (104,473) — (104,473) $7.16 Non-vested at September 30, 2020 2,416,388 803,908 3,220,296 $6.77 1.03 $27,534 Expected to vest 3,220,296 $6.77 1.03 $27,534
Share-based Payment Arrangement, Expensed and Capitalized, Amount	Stock-based compensation was included in the following captions in our condensed consolidated statements of operations for the nine months ended September 30, 2020 and 2019 (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Cost of products revenues $ 150 $ 103 $ 370 $ 244 Cost of services revenues 283 82 539 177 Research and development expenses 546 305 1,199 762 Marketing and selling expenses 739 532 1,761 1,276 General and administrative expenses 1,579 1,023 4,263 3,329 $ 3,297 $ 2,045 $ 8,132 $ 5,788

FINANCIAL INFORMATION New Accou

FINANCIAL INFORMATION New Accounting Pronouncements Adopted (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Forgivable PPP Loan COVID-19	$ 7,800	$ 0
COVID-19 [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Forgivable PPP Loan COVID-19		$ 7,800

NET INCOME PER SHARE Earnings_3

NET INCOME PER SHARE Earnings Per Share (Details) - shares shares in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Antidilutive Securities Excluded from Computation of Net Loss Per Share [Line Items]
Anti-dilutive potential common shares (in thousands of shares)	3,610	3,293
Options
Antidilutive Securities Excluded from Computation of Net Loss Per Share [Line Items]
Anti-dilutive potential common shares (in thousands of shares)	390	594
Non-vested restricted stock units
Antidilutive Securities Excluded from Computation of Net Loss Per Share [Line Items]
Anti-dilutive potential common shares (in thousands of shares)	3,220	2,699

NET INCOME PER SHARE Weighted A

NET INCOME PER SHARE Weighted Average Shares Outstanding (Details) - shares shares in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2020	Mar. 31, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Earnings Per Share [Abstract]
Weighted-average common shares outstanding – basic	44,019		42,913	43,665	42,510
Net effect of common stock equivalents		739		833
Weighted-average common shares outstanding – diluted	44,758		43,674	44,498	42,510

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details) - Fair Value, Recurring [Member] - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Financial Assets:
Deferred compensation assets	$ 487	$ 1,156
Quoted Prices in Active Markets for Identical Assets (Level 1)
Financial Assets:
Deferred compensation assets	261	338
Significant Other Observable Inputs (Level 2)
Financial Assets:
Deferred compensation assets	226	818
Significant Unobservable Inputs (Level 3)
Financial Assets:
Deferred compensation assets	$ 0	$ 0

INVENTORIES (Details)

INVENTORIES (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Raw materials	$ 7,885	$ 9,036
Work in process	316	371
Finished Goods	20,177	19,759
Total inventory	28,378	29,166
Finished goods, consigned	$ 1,700	$ 1,500

LEASES LEASES (Details)

LEASES LEASES (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Lessee, Lease, Description [Line Items]
Operating Lease, Weighted Average Discount Rate, Percent	6.00%		6.00%
Operating Lease, Weighted Average Remaining Lease Term	6 years 7 months 6 days		6 years 7 months 6 days
Operating Lease, Cost	$ 2.2	$ 2.4	$ 7.2	$ 7.2
Operating Lease, Payments	$ 2	$ 2.4	$ 6.9	$ 7.3
Finance Lease, Weighted Average Discount Rate, Percent	2.30%		2.30%
Minimum [Member]
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Term of Contract	1 year		1 year
Maximum [Member]
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Term of Contract	8 years		8 years

LEASES Maturity Schedule (Detai

LEASES Maturity Schedule (Details) $ in Thousands	Sep. 30, 2020USD ($)
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
2020 (excluding nine months ended September 30, 2020)	$ 2,067
2021	7,590
2022	6,472
2023	5,579
2024	4,875
Thereafter	16,637
Total future minimum lease payments	43,220
Less effects of discounting	(7,837)
Total lease liabilities	(35,383)
Finance Lease, Liability, Payment, Due [Abstract]
2020 (excluding nine months ended September 30, 2020)	12
2021	289
2022	255
2023	226
2024	0
Thereafter	0
Total future minimum lease payments	782
Less effects of discounting	27
Total lease liabilities	$ 755

LEASES Supplemental Balance She

LEASES Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Leases [Abstract]
Right of use assets	$ 30,408	$ 29,747
Accrued expenses and other current liabilities	(5,910)
Operating lease liabilities (LT)	(29,473)	(28,127)
Total lease liabilities	(35,383)
Finance Lease, Right-of-Use Asset	737
Finance Lease, Liability, Current	(220)
Finance Lease, Liability, Noncurrent	(535)	$ 0
Lessee, Lease, Description [Line Items]
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$ 5,700

OTHER LONG-TERM LIABILITIES (De

OTHER LONG-TERM LIABILITIES (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Other Liabilities Disclosure [Abstract]
Deferred compensation	$ 5,335	$ 5,186
Finance Lease, Liability, Noncurrent	535	0
Other	292	460
Total	$ 6,162	$ 5,646

CONTINGENCIES (Details)

CONTINGENCIES (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2019
Product warranty accrual [Roll Forward]
Accrual balance at beginning of year		$ 1,337	$ 1,706
Accruals for product warranties		1,030	732
Cost of warranty claims		(1,003)	(1,016)
Accrual balance at end of period	$ 1,364	1,364	$ 1,422
Standby Letters of Credit [Member] | Office Space - Burlington, Massachusetts [Member]
Loss Contingencies [Line Items]
Loss Contingency, Range of Possible Loss, Portion Not Accrued	1,300	1,300
Loss Contingency, Range Of Possible Loss, Portion Not Accrued, Minimum	1,200	1,200
Standby Letters of Credit [Member] | Office Space - Other Facilities [Member]
Loss Contingencies [Line Items]
Letters of Credit Outstanding, Amount	600	600
Standby Letters of Credit [Member] | Other Operating Obligations [Member]
Loss Contingencies [Line Items]
Letters of Credit Outstanding, Amount	1,900	1,900
Research and Development Arrangement [Member]
Loss Contingencies [Line Items]
Long-term Purchase Commitment, Amount	$ 32,200
Long-term Purchase Commitment, Period	5 years
Other Inventory, Purchased Goods, Gross	$ 600	$ 600

RESTRUCTURING COSTS AND ACCRU_3

RESTRUCTURING COSTS AND ACCRUALS (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2018
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	$ 723	$ 229	$ 1,008	$ 518
Restructuring and Related Cost, Incurred Cost	723	202	1,008	478
Restructuring accrual [Roll Forward]
New restructuring charges - operating expenses	723	229	1,008	518
Facilities-related accruals - current					$ 100
Facilities-related accruals - non-current					$ 200
Employee
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	700	200
Restructuring accrual [Roll Forward]
Accrual balance at beginning of year			155
New restructuring charges - operating expenses	723	202	911	473
Cash payments			(258)
Accrual balance at end of period	808		808
Facilities-related accruals - current	808		808
Facilities-related accruals - non-current	0		0
Facility
Restructuring accrual [Roll Forward]
New restructuring charges - operating expenses	0	0	97	5
Other
Restructuring Cost and Reserve [Line Items]
Other Restructuring Costs	$ 0	$ 27	$ 0	$ 40

REVENUE Revenue by Type (Detail

REVENUE Revenue by Type (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2019USD ($)
Revenue from Contract with Customer [Abstract]
Number of reportable segments			1
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	$ 90,431	$ 93,461	$ 256,165	$ 295,481
Products and solutions net revenues
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	35,775		98,121
Subscription services
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	17,907	10,297	48,292	29,339
Support services
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	30,826	33,361	93,190	97,018
Professional services, training and other services
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	$ 5,923	$ 6,892	$ 16,562	$ 21,491

REVENUE Revenue by Geographic R

REVENUE Revenue by Geographic Regions (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	$ 90,431	$ 93,461	$ 256,165	$ 295,481
United States
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	36,190	31,267	105,166	110,697
Other Americas
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	4,505	9,471	15,841	23,232
Europe, Middle East and Africa
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	37,537	40,579	99,478	115,171
Asia-Pacific
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenues	$ 12,199	$ 12,144	$ 35,680	$ 46,381

REVENUE Contract Asset (Details

REVENUE Contract Asset (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2020USD ($)
Change in Contract with Customer, Asset [Abstract]
Contract asset at January 1, 2020	$ 19,494
Revenue in excess of billings	22,045
Customer billings	(26,263)
Contract asset at September 30, 2020	$ 15,276

REVENUE Deferred Revenue Activi

REVENUE Deferred Revenue Activity (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2020
Movement in Deferred Revenue [Roll Forward]
Deferred revenue at January 1, 2020	$ 97,901
Billings deferred	47,723
Recognition of prior deferred revenue	(64,460)
Deferred revenue at September 30, 2020	81,164
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation		$ 53,700
Deferred Revenue	$ 81,164	81,164
Products
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation		5,133
Subscription services
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation		3,320
Support contracts
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation		61,596
Implied PCS
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation		8,860
Professional services, training and other
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation		$ 2,255

REVENUE Remaining Performance O

REVENUE Remaining Performance Obligations (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Deferred Revenue Arrangement [Line Items]
Revenue, Performance Obligation, Description of Timing	six years
Remaining Performance Obligation	$ 53,700
Unbilled Receivables, Not Billable	48,100
Products
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation	5,133
Subscription services
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation	3,320
Support contracts
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation	61,596
Implied PCS
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation	8,860
Implied PCS | Forecast [Member]
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation		$ 500	$ 800	$ 1,200	$ 2,000	$ 3,300	$ 1,100
Professional services, training and other
Deferred Revenue Arrangement [Line Items]
Remaining Performance Obligation	$ 2,255

LONG-TERM DEBT AND CREDIT AGR_3

LONG-TERM DEBT AND CREDIT AGREEMENT Debt Disclosure (Details) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Debt Instrument, Periodic Payment, Principal	$ 833
Long-term Debt, Maturities, Repayments of Principal in Year Two	4,934
Long-term Debt, Maturities, Repayments of Principal in Year Three	14,339
Long-term Debt, Maturities, Repayments of Principal in Year Four	190,228
Long-term Debt, Maturities, Repayments of Principal in Year Five	188
Long-term Debt, Maturities, Repayments of Principal after Year Five	533
Total debt	211,055
Convertible Notes unamortized issue discount and debt issuance costs	2,846
Short-term debt	4,135	$ 30,554
Long-term Debt	204,074	$ 199,034
Federal Home Loan Bank Advances
Debt Instrument, Periodic Payment, Principal	0
Long-term Debt, Maturities, Repayments of Principal in Year Two	0
Long-term Debt, Maturities, Repayments of Principal in Year Three	7,800
Long-term Debt, Maturities, Repayments of Principal in Year Four	0
Long-term Debt, Maturities, Repayments of Principal in Year Five	0
Long-term Debt, Maturities, Repayments of Principal after Year Five	0
Total debt	7,800
Convertible Notes unamortized issue discount and debt issuance costs	0
Short-term debt	0
Long-term Debt	$ 7,800

LONG-TERM DEBT AND CREDIT AGR_4

LONG-TERM DEBT AND CREDIT AGREEMENT Debt Disclosurre (Details) - USD ($)	May 19, 2020	Jun. 28, 2019	May 13, 2019	May 02, 2019	Apr. 08, 2019	Jan. 22, 2019	May 10, 2018	Dec. 15, 2017	Feb. 26, 2016	Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019	May 09, 2019	Feb. 08, 2018	Nov. 09, 2017	Jun. 15, 2015
Debt Instrument, Periodic Payment, Principal										$ 833,000	$ 833,000					$ 833,000
Term Loan, net of unamortized debt issuance costs										199,159,000	199,159,000					199,159,000		$ 200,105,000
Notes, net of unamortized original issue discount and debt issuance costs										0	0					0		28,187,000
Loans Payable										7,800,000	7,800,000					7,800,000		0
Other Long-term Debt										1,250,000	1,250,000					1,250,000		1,296,000
Total debt										208,209,000	208,209,000					208,209,000		229,588,000
Short-term debt										4,135,000	4,135,000					4,135,000		30,554,000
Long-term Debt										204,074,000	204,074,000					204,074,000		$ 199,034,000
Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction					$ 1,600,000											289,000	$ 5,979,000
Debt Related Commitment Fees and Debt Issuance Costs					$ 4,400,000
Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt													$ (554,000)	$ (23,000)
Interest Expense											4,423,000	$ 5,519,000				15,204,000	23,994,000
Convertible Debt Retired						3,900		2,000										16,247	73,986
Convertible Debt Issued						106,753														123,000		125,000
Extinguishment of Debt, Amount			$ 74,000,000			$ 3,900,000		$ 2,000,000							$ 16,200,000
Debt Instrument, Discounted Repurchase Amount			982.50
Debt Instrument, Face Amount																						$ 1,000
Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments			600,000
Loss (Gain) on Extinguishment of Debt			$ 2,900,000													0	$ 2,878,000
Convertible Note Options Outstanding			28,867
Repayments of Debt			$ 72,700,000			$ 3,600,000		$ 1,700,000							14,700,000
Convertible Notes unamortized issue discount and debt issuance costs										2,846,000	2,846,000					2,846,000
Long-term Debt, Maturities, Repayments of Principal in Year Two										4,934,000	4,934,000					4,934,000
Long-term Debt, Maturities, Repayments of Principal in Year Three										14,339,000	14,339,000					14,339,000
Long-term Debt, Maturities, Repayments of Principal in Year Four										190,228,000	190,228,000					190,228,000
Long-term Debt, Maturities, Repayments of Principal in Year Five										188,000	188,000					188,000
Long-term Debt, Maturities, Repayments of Principal after Year Five										533,000	533,000					533,000
Total debt										$ 211,055,000	$ 211,055,000					$ 211,055,000
Debt Instrument, Prepayment Premium Percentage										1.50%	1.50%					1.50%
Debt Instrument, Prepayment Premium Percentage, Year One										0.50%	0.50%					0.50%
Debt Instrument, Prepayment Premium Percentage, Thereafter										0.00%	0.00%					0.00%
Debt Instrument, Leverage Ratio, Period One										600.00%	600.00%					600.00%
Debt Instrument, Leverage Ratio, Period Two										575.00%	575.00%					575.00%
Debt Instrument, Leverage Ratio, Period Three										525.00%	525.00%					525.00%
Debt Instrument, Leverage Ratio, Period Four										500.00%	500.00%					500.00%
Debt Instrument, Leverage Ratio, Period Five										450.00%	450.00%					450.00%
Debt Instrument, Leverage Ratio, Period Six										430.00%	430.00%					430.00%
Debt Instrument, Leverage Ratio, Period Seven										400.00%	400.00%					400.00%
Debt Instrument, Leverage Ratio, Period Eight										375.00%	375.00%					375.00%
LONG TERM DEBT AND CREDIT AGREEMENT																LONG-TERM DEBT AND CREDIT AGREEMENT Long-term debt consisted of the following (in thousands): September 30, 2020 December 31, 2019 Term Loan, net of debt issuance costs of $2,846 at September 30, 2020 and $3,334 at December 31, 2019 $ 199,159 $ 200,105 Notes, net of unamortized original issue discount and debt issuance costs of $0 at September 30, 2020 and $680 at December 31, 2019 — 28,187 PPP Loan 7,800 — Other long-term debt 1,250 1,296 Total debt 208,209 229,588 Less: current portion 4,135 30,554 Total long-term debt $ 204,074 $ 199,034 The following table summarizes the contractual maturities of our borrowing obligations as of September 30, 2020 (in thousands): Fiscal Year Term Loan PPP Loan Other Long-Term Debt Total 2020 $ 797 $ — $ 36 $ 833 2021 4,781 — 153 4,934 2022 6,375 7,800 164 14,339 2023 190,052 — 176 190,228 2024 — — 188 188 Thereafter — — 533 533 Total before unamortized discount 202,005 7,800 1,250 211,055 Less: unamortized discount and issuance costs 2,846 — — 2,846 Less: current portion of long-term debt 3,985 — 150 4,135 Total long-term debt $ 195,174 $ 7,800 $ 1,100 $ 204,074 Term Loan and Credit Facility On February 26, 2016, we entered into a financing agreement (the “Financing Agreement”) with Cerberus Business Finance, LLC, as collateral and administrative agent, and the lenders party thereto (the “Lenders”). The Lenders originally agreed to provide us with (a) a term loan in the aggregate principal amount of $100.0 million (the “Term Loan”), and (b) a revolving credit facility (the “Credit Facility”) of up to a maximum of $5.0 million in borrowings outstanding at any time. We granted a security interest on substantially all of our assets to secure the obligations under the Term Loan and the Credit Facility. The Term Loan requires us to use 50% of excess cash flow, as defined in the Financing Agreement, to repay outstanding principal of the loans under the Financing Agreement. The Financing Agreement contains customary representations and warranties, covenants, mandatory prepayments, and events of default under which our payment obligations may be accelerated. On November 9, 2017, we entered into an amendment and borrowed an additional $15.0 million term loan and increased the amount available under the Credit Facility by $5.0 million. On May 10, 2018, we entered into an amendment to the Financing Agreement, which extended the maturity of the Financing Agreement to May 2023, and increased the Term Loan by $22.7 million and the amount available under the Credit Facility by $12.5 million, for an aggregate amount available of $22.5 million. On April 8, 2019, we entered into an amendment to the Financing Agreement. The amendment provided for an additional delayed draw term loan commitment in the aggregate principal amount of $100.0 million (the “Delayed Draw Funds”) for the purpose of funding the purchase of a portion of Notes in the Offer described below. On May 2, 2019, we received the Delayed Draw Funds under the Financing Agreement. We used $72.7 million of the Delayed Draw Funds for the purchase of a portion of our Notes, $0.6 million for the Notes interest payment, and $6.0 million for the payment of refinancing fees. On June 18, 2019, we repaid $20.7 million of the Delayed Draw Funds. The $79.3 million Delayed Draw Funds borrowed and that remain outstanding will mature on May 10, 2023 under the terms of the Financing Agreement. The amendment also modified the covenant that requires us to maintain a leverage ratio (defined to mean the ratio of (a) the sum of indebtedness under the Term Loan and Credit Facility and non-cash collateralized letters of credit to (b) consolidated EBITDA under the Term Loan and Credit Facility) based on the level of availability of our Credit Facility plus unrestricted cash on-hand. The Financing Agreement amendment effective April 8, 2019 was accounted for as a debt modification, and therefore, $1.6 million of the refinancing fees paid directly to the Lenders was recorded as deferred debt issuance costs, and $4.4 million of the refinancing fees paid to the third parties was expensed. On May 7, 2020, we entered into an amendment to the Financing Agreement. The amendment modified certain definitions in the Financing Agreement to reflect our incurrence of a loan under the PPP. On May 19, 2020, we entered into an amendment to the Financing Agreement. The amendment increased the applicable margin with respect to the interest rate of reference rate loans from 5.25% to 5.75% and of LIBOR rate loans from 6.25% to 6.75%. The amendment also increased the leverage ratio that the Company is required to maintain such that following the effective date of this amendment, the Company is required to maintain a leverage ratio of no greater than 6.00:1.00 for each of the quarters ending June 30, 2020 and September 30, 2020, 5.75:1.00 for each of the quarters ending December 31, 2020 and March 31, 2021, 5.25:1.00 for the quarter ending June 30, 2021, 5.00:1.00 for the quarter ending September 30, 2021, 4.50:1.00 for the quarter ending December 31, 2021, 4.30:1.00 for the quarter ending March 31, 2022, 4.00:1.00 for each of the quarters ending June 30, 2022 and September 30, 2022, and 3.75:1.00 for each of the quarters ending December 31, 2022 and March 31, 2023. The amendment also resets the prepayment premium to 1.5% of the principal amount of the loans prepaid through the end of 2020, 0.5% of the principal amount of the loans prepaid through the end of 2021, and 0.0% thereafter. We recorded $3.8 million and $12.2 million of interest expense on the Term Loan during the three and nine months ended September 30, 2020, respectively. We recognized $0.4 million and $0.8 million of interest expense related to the Credit Facility during the three and nine months ended September 30, 2020, respectively. We were in compliance with the Financing Agreement covenants as of September 30, 2020. At June 30, 2020, we had $22.0 million outstanding under the Credit Facility. During September 2020, we repaid the outstanding balance of $22.0 million under the Credit Facility, and as of September 30, 2020 no amounts were drawn under the facility. PPP Loan On May 11, 2020, the Company received $7.8 million of proceeds in connection with its incurrence of a loan under the PPP which was created through the Coronavirus Aid, Relief, and Economic Act (“CARES Act”) and is administered by the U.S. Small Business Administration (“SBA”). The application for these funds requires the Company to, in good faith, certify that the current economic uncertainty made the loan request necessary to support the ongoing operations of the Company. This certification further requires the Company to take into account our current business activity and our ability to access other sources of liquidity sufficient to support ongoing operations in a manner that is not significantly detrimental to the business. The receipt of these funds, and the forgiveness of the loan attendant to these funds, is dependent on the Company having initially qualified for the loan and qualifying for the forgiveness of such loan based on our future adherence to the forgiveness criteria. The loan has a fixed interest rate of 1% and matures in two years. Interest payments are deferred for six months. We recognized an immaterial amount of interest expense related to the loan during the three months ended September 30, 2020. Pursuant to the CARES Act and implementing rules and regulations, the Company may apply to the SBA for the PPP loan to be forgiven in whole or in part beginning no sooner than seven weeks from the date of initial disbursement. The Company intends to use the proceeds of the PPP loan for purposes consistent with the PPP. While the Company currently believes that its use of the loan proceeds will meet the conditions for forgiveness of the loan, the Company cannot assure that it will be eligible for forgiveness of the loan, in whole or in part. Any PPP loan balance remaining following forgiveness by the SBA will be fully re-amortized over the remaining term of the loan. 2.00% Convertible Senior Notes due 2020 (“Notes”) On June 15, 2015, we issued $125.0 million aggregate principal amount of our Notes in an offering conducted in accordance with Rule 144A under the Securities Act. During 2017, we purchased 2,000 of our 125,000 outstanding Notes and settled $2.0 million of the Notes for $1.7 million in cash. We recorded $2.0 million extinguishment of debt, an immaterial amount of equity reacquisition, and an immaterial loss on the extinguishment of debt. During 2018, we purchased an additional 16,247 of our 123,000 outstanding Notes and settled another $16.2 million of the Notes for $14.7 million in cash. We recorded $16.2 million extinguishment of debt, an immaterial amount of equity reacquisition, and an immaterial gain on the extinguishment of debt. On January 22, 2019, we purchased an additional 3,900 of our 106,753 outstanding Notes and settled another $3.9 million of the Notes for $3.6 million in cash. We recorded $3.9 million extinguishment of debt, an immaterial amount of equity reacquisition, and an immaterial gain on the extinguishment of debt. On April 11, 2019, we announced the commencement of a cash tender offer (the “Offer”) for any and all of our outstanding Notes. On May 9, 2019, as of the expiration of the Offer, Notes with an aggregate principal amount of $74.0 million were validly tendered. We accepted for purchase all Notes that were validly tendered at the expiration of the Offer at a purchase price equal to $982.50 per $1,000 principal amount of Notes, and settled the Offer on May 13, 2019 for $72.7 million in cash. We repurchased 73,986 Notes, recorded $74.0 million extinguishment of debt, $0.6 million of equity reacquisition, and $2.9 million loss on the extinguishment of debt. In connection with the Offer, the number of options under the Capped Call was reduced to 28,867 to mirror the remaining principal outstanding for the Notes, and an immaterial partial unwind cash payment was received in May 2019. On June, 15, 2020, the maturity date of the Notes, we fully repaid the outstanding principal and unpaid interest on the Notes. The Notes paid interest semi-annually on June 15 and December 15 of each year at an annual rate of 2.00%. Total interest expense for the nine months ended September 30, 2020 was $1.0 million, reflecting the coupon and accretion of the discount.
Minimum [Member]
Debt Instrument, Basis Spread on Variable Rate	5.25%
Maximum [Member]
Debt Instrument, Basis Spread on Variable Rate	5.75%
London Interbank Offered Rate (LIBOR) [Member] | Minimum [Member]
Debt Instrument, Basis Spread on Variable Rate	6.25%
London Interbank Offered Rate (LIBOR) [Member] | Maximum [Member]
Debt Instrument, Basis Spread on Variable Rate	6.75%
Revolving Credit Facility [Member]
Long-term Debt															$ 22,000,000
Repayments of Debt										$ 22,000,000
Other Debt Obligations [Member]
Debt Instrument, Periodic Payment, Principal										36,000	$ 36,000					$ 36,000
Short-term debt										150,000	150,000					150,000
Long-term Debt										1,100,000	1,100,000					1,100,000
Convertible Notes unamortized issue discount and debt issuance costs										0	0					0
Long-term Debt, Maturities, Repayments of Principal in Year Two										153,000	153,000					153,000
Long-term Debt, Maturities, Repayments of Principal in Year Three										164,000	164,000					164,000
Long-term Debt, Maturities, Repayments of Principal in Year Four										176,000	176,000					176,000
Long-term Debt, Maturities, Repayments of Principal in Year Five										188,000	188,000					188,000
Long-term Debt, Maturities, Repayments of Principal after Year Five										533,000	533,000					533,000
Total debt										1,250,000	1,250,000					1,250,000
Cerberus Business Finance LLC [Member]
Debt Instrument, Periodic Payment, Principal										797,000	797,000					797,000
Short-term debt										3,985,000	3,985,000					3,985,000
Long-term Debt										195,174,000	195,174,000					195,174,000
Convertible Notes unamortized issue discount and debt issuance costs										2,846,000	2,846,000					2,846,000
Long-term Debt, Maturities, Repayments of Principal in Year Two										4,781,000	4,781,000					4,781,000
Long-term Debt, Maturities, Repayments of Principal in Year Three										6,375,000	6,375,000					6,375,000
Long-term Debt, Maturities, Repayments of Principal in Year Four										190,052,000	190,052,000					190,052,000
Long-term Debt, Maturities, Repayments of Principal in Year Five										0	0					0
Long-term Debt, Maturities, Repayments of Principal after Year Five										0	0					0
Total debt										202,005,000	202,005,000					202,005,000
Convertible Debt [Member]
Long-term Debt, Gross																						$ 125,000,000
Debt Instrument, Interest Rate, Stated Percentage																						2.00%
Interest Expense																1,000,000
Convertible Notes unamortized issue discount and debt issuance costs										0	0					0		$ 680,000
Federal Home Loan Bank Advances
Debt Instrument, Periodic Payment, Principal										0	0					0
Short-term debt										0	0					0
Long-term Debt										7,800,000	7,800,000					7,800,000
Convertible Notes unamortized issue discount and debt issuance costs										0	0					0
Long-term Debt, Maturities, Repayments of Principal in Year Two										0	0					0
Long-term Debt, Maturities, Repayments of Principal in Year Three										7,800,000	7,800,000					7,800,000
Long-term Debt, Maturities, Repayments of Principal in Year Four										0	0					0
Long-term Debt, Maturities, Repayments of Principal in Year Five										0	0					0
Long-term Debt, Maturities, Repayments of Principal after Year Five										0	0					0
Total debt										7,800,000	7,800,000					7,800,000
Federal Home Loan Bank Advances [Member]
Long-term Debt										7,800,000	7,800,000					7,800,000
Cerberus Business Finance LLC [Member]
Debt Instrument, Covenant Description					On April 8, 2019, we entered into an amendment to the Financing Agreement. The amendment provided for an additional delayed draw term loan commitment in the aggregate principal amount of $100.0 million (the “Delayed Draw Funds”) for the purpose of funding the purchase of a portion of Notes in the Offer described below. On May 2, 2019, we received the Delayed Draw Funds under the Financing Agreement. We used $72.7 million of the Delayed Draw Funds for the purchase of a portion of our Notes, $0.6 million for the Notes interest payment, and $6.0 million for the payment of refinancing fees. On June 18, 2019, we repaid $20.7 million of the Delayed Draw Funds. The $79.3 million Delayed Draw Funds borrowed and that remain outstanding will mature on May 10, 2023 under the terms of the Financing Agreement. The amendment also modified the covenant that requires us to maintain a leverage ratio (defined to mean the ratio of (a) the sum of indebtedness under the Term Loan and Credit Facility and non-cash collateralized letters of credit to (b) consolidated EBITDA under the Term Loan and Credit Facility) based on the level of availability of our Credit Facility plus unrestricted cash on-hand.		On May 10, 2018, we entered into an amendment to the Financing Agreement, which extended the maturity of the Financing Agreement to May 2023, and increased the Term Loan by $22.7 million and the amount available under the Credit Facility by $12.5 million, for an aggregate amount available of $22.5 million.		We granted a security interest on substantially all of our assets to secure the obligations under the Term Loan and the Credit Facility. The Term Loan requires us to use 50% of excess cash flow, as defined in the Financing Agreement, to repay outstanding principal of the loans under the Financing Agreement. The Financing Agreement contains customary representations and warranties, covenants, mandatory prepayments, and events of default under which our payment obligations may be accelerated.
Proceeds from Loans							$ 22,500,000
additional long term debt																					$ 15,000,000
Cerberus Business Finance LLC [Member] | Line of Credit [Member]
Line of Credit Facility, Maximum Borrowing Capacity									$ 5,000,000
Cerberus Business Finance LLC [Member] | Long-term Debt [Member]
Unamortized Debt Issuance Expense										$ 2,846,000	2,846,000					2,846,000		$ 3,334,000
Long-term Debt									100,000,000
Interest Expense, Long-term Debt											3,800,000					12,200,000
Term Loan, Net, Period Increase (Decrease)							22,700,000
Cerberus Business Finance LLC [Member] | Long-term Debt [Member] | Revolving Credit Facility [Member]
Interest Expense, Long-term Debt											$ 400,000					$ 800,000
Cerberus Business Finance LLC [Member] | Long-term Debt [Member] | Delayed Draw Funds
Long-term Debt		$ 79,300,000			$ 100,000,000
Repayments of Long-term Debt		$ 20,700,000
Cerberus Business Finance LLC [Member] | Line of Credit [Member]
Line of Credit Facility, Maximum Borrowing Capacity									$ 5,000,000
Debt Instrument, Restrictive Covenant, Excess Cash Flow Payment Requirement, As A Percentage									50.00%
Line of Credit Facility, Increase (Decrease), Net							$ 12,500,000
Convertible Debt [Member]
Repayments of Senior Debt				$ 72,700,000
Interest Expense				600,000
Payments of Financing Costs				$ 6,000,000

STOCKHOLDERS' EQUITY Options Ac

STOCKHOLDERS' EQUITY Options Activity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Share-based Payment Arrangement, Expense	$ 3,297	$ 2,045	$ 8,132	$ 5,788
Share-based Payment Arrangement, Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	389,645		389,645		565,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures			0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period			(175,355)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period			0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 7.51		$ 7.51		$ 7.57
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price			0
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price			7.73
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price			$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term			6 months 14 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 413		$ 413
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	389,645		389,645
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price	$ 7.51		$ 7.51
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term			6 months 14 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value	$ 413		$ 413
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number	389,645		389,645
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 7.51		$ 7.51
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term			6 months 14 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value	$ 413		$ 413
Share-based Payment Arrangement, Option [Member] | Time-Based Vesting [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	389,645		389,645		565,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures			0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period			(175,355)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period			0
Share-based Payment Arrangement, Option [Member] | Performance-Based Vesting [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	0		0		0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures			0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period			0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period			0

STOCKHOLDERS' EQUITY Non-vested

STOCKHOLDERS' EQUITY Non-vested Restricted Stock (Details) - Restricted Stock Units (RSUs) [Member] - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	3,220,296	2,642,198
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	2,002,796
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	(1,320,225)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	(104,473)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 6.77	$ 6.40
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	6.92
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value	6.23
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value	$ 7.16
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms	1 year 10 days
Share-based Compensation Arrangement by Share-based Payment Award, Non-vested Restricted Stock Aggregate Intrinsic Value	$ 27,534
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected to Vest Number	3,220,296
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest Weighted Average Grant Date Fair Value	$ 6.77
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected to Vest Weighted Average Remaining Contractual Term	1 year 10 days
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest Intrinsic Value	$ 27,534
Time-Based Vesting [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	2,416,388	2,087,933
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	1,424,480
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	(991,552)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	(104,473)
Performance-Based Vesting [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	803,908	554,265
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	578,316
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	(328,673)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period	0

STOCKHOLDERS' EQUITY Stock-base

STOCKHOLDERS' EQUITY Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Share-based Payment Arrangement, Expense	$ 3,297	$ 2,045	$ 8,132	$ 5,788
Cost of Products Revenues [Member]
Share-based Payment Arrangement, Expense	150	103	370	244
Cost of Services Revenues [Member]
Share-based Payment Arrangement, Expense	283	82	539	177
Research and Development Expense [Member]
Share-based Payment Arrangement, Expense	546	305	1,199	762
Selling and Marketing Expense [Member]
Share-based Payment Arrangement, Expense	739	532	1,761	1,276
General and Administrative Expense [Member]
Share-based Payment Arrangement, Expense	$ 1,579	$ 1,023	$ 4,263	$ 3,329

Uncategorized Items - avid-2020

Label	Element	Value
Increase (Decrease) in Restructuring Reserve	us-gaap_IncreaseDecreaseInRestructuringReserve	$ 0
Increase (Decrease) in Restructuring Reserve	us-gaap_IncreaseDecreaseInRestructuringReserve	$ 653,000